Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-06T12:20:00.926Z Has data issue: false hasContentIssue false

Should elective neck dissection be routinely performed in patients undergoing salvage total laryngectomy?

Published online by Cambridge University Press:  17 March 2014

T F Pezier*
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
I J Nixon
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
W Scotton
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
A Joshi
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
T Guerrero-Urbano
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
R Oakley
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
J-P Jeannon
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
R Simo
Affiliation:
Department of Otorhinolaryngology Head and Neck Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, UK
*
Address for correspondence: Mr T Pezier, ORL-Klinik, University Hospital Zurich, 8008 Zurich, Switzerland E-mail: tfrpezier@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Background:

The prevalence of occult neck metastasis in patients undergoing salvage total laryngectomy remains unclear, and there is controversy regarding whether elective neck dissection should routinely be performed.

Method:

A retrospective case note review of 32 consecutive patients undergoing salvage total laryngectomy in a tertiary centre was performed, in order to correlate pre-operative radiological staging with histopathological staging.

Results:

The median patient age was 61 years (range, 43–84 years). With regard to lymph node metastasis, 28 patients were pre-operatively clinically staged (following primary radiotherapy or chemoradiotherapy) as node-negative, 1 patient was staged as N1, two patients as N2c and one patient as N3. Fifty-two elective and seven therapeutic neck dissections were performed. Pathological analysis up-staged two patients from clinically node-negative (following primary radiotherapy or chemoradiotherapy) to pathologically node-positive (post-surgery). No clinically node-positive patients were down-staged. More than half of the patients suffered a post-operative fistula.

Conclusion:

Pre-operative neck staging had a negative predictive value of 96 per cent. Given the increased complications associated with neck dissection in the salvage setting, consideration should be given to conservative management of the neck in clinically node-negative patients (staged following primary radiotherapy or chemoradiotherapy).

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2014 

Introduction

Radiotherapy (RT) and chemoradiotherapy have become standard treatments for patients with all but the most advanced squamous cell carcinoma (SCC) of the larynx. Laser excision is an option for early cancer. Primary total laryngectomy is often performed for advanced bulky disease, though some patients with quite advanced cancer are still also suitable for chemoradiotherapy.Reference Forastiere, Goepfert, Maor, Pajak, Weber and Morrison1 High local control has been reported in randomised controlled trials of chemoradiotherapy. Nevertheless, around 10 per cent of patients undergo salvage total laryngectomy because of persistent or recurrent disease.

Elective neck dissection performed at the time of primary total laryngectomy is recommended for supraglottic and glottic grade 4 tumours (National Comprehensive Cancer Network Guidelines®). In this way, occult neck disease, which can be missed in up to 30 per cent of patients on pre-operative staging, is treated.

However, the position is less clear in the salvage setting. Salvage neck surgery is challenging, and affected patients are at a high risk of post-operative complications and prolonged hospital stay.Reference Bohannon, Desmond, Clemons, Magnuson, Carroll and Rosenthal2, Reference Weber, Berkey, Forastiere, Cooper, Maor and Goepfert3 If such patients could be reliably pre-operatively staged, those considered free of neck disease could potentially be managed without elective neck dissections. This would reduce post-operative complications such as pharyngocutaneous fistula.

The frequency of occult nodal disease in recurrent laryngeal cancer has been reported to range from 3 to 17 per cent, with a higher trend of up to 28 per cent in supraglottic recurrence.Reference Bohannon, Desmond, Clemons, Magnuson, Carroll and Rosenthal2, Reference Farrag, Lin, Cummings, Koch, Flint and Califano4, Reference Wax and Touma5 It is unclear why such variation exists in the literature. Furthermore, technological radiological developments continue apace, meaning that historical datasets may not be applicable to current practice.

This study aimed to assess the negative predictive value of contemporary pre-operative investigation in patients undergoing salvage laryngectomy. We also briefly describe our complication rates though these are more thoroughly described in a previous publication from our unit.Reference Scotton, Cobb, Pang, Nixon, Joshi and Jeannon6

Materials and methods

After local ethics committee approval, a retrospective analysis was performed of 32 consecutive patients who underwent salvage total laryngectomy following primary RT or chemoradiotherapy for laryngeal SCC between 2003 and 2010.

All patients underwent pre-operative computed tomography (CT) scanning of the neck and thorax, magnetic resonance imaging (MRI), and fine needle aspiration cytology (FNAC) when indicated. Patients’ treatment was planned in our multidisciplinary head and neck tumour board meetings. Only patients with no evidence of distant metastasis and those treated with curative intent were included in this analysis.

In line with our multidisciplinary team's normal approach, salvage laryngectomy patients with evidence of neck disease were managed with bilateral modified radical neck dissections. Patients without evidence of neck disease underwent bilateral selective neck dissection of levels 2–4.

Following surgery, routine pathological analysis of neck specimens was performed. These results were then compared with the tumour board pre-operative documentation. As a secondary exercise, we collected survival data from follow-up consultations to investigate survival outcomes associated with pathological lymph node metastasis stage using the Kaplan–Meier method.

Results and analysis

Patients

A total of 32 patients underwent surgery between October 2003 and July 2010. Twenty-nine patients were male, three were female. The median patient age at the time of the procedure was 61 years (range, 43–84 years). All patients underwent total laryngectomy, and 9 of the 32 patients (28 per cent) also underwent partial pharyngectomy. Twenty-nine patients (91 per cent) underwent bilateral neck dissections, one (3 per cent) underwent a unilateral neck dissection and two (6 per cent) had no neck dissection.

Oncological outcomes

With a median follow up of 18 months (range, 1–106 months) for the whole cohort, 5-year overall survival was 37 per cent, disease-specific survival was 47.4 per cent, locoregional recurrence free survival was 71.7 per cent and distant recurrence free survival was 95.5 per cent (Figure 1).

Fig. 1 Kaplan–Meier survival curves following salvage laryngectomy. DRFS = distant recurrence free survival; LRRFS = locoregional recurrence free survival; DSS = disease-specific survival; OS = overall survival

The pathological lymph node metastasis (N) stage is known to be an important predictor of outcome in head and neck cancer. However, possibly because of our small cohort, overall survival of pathologically staged N+ patients was not statistically significantly worse than pathologically staged N0 patients (p > 0.05) (Figure 2).

Fig. 2 Kaplan–Meier overall survival curves for patients pathologically staged as node-positive (‘ypN + ’) versus those staged as node-negative (‘ypN0’) (p > 0.05).

Negative predictive value

Twenty-eight patients were pre-operatively clinically staged (following primary RT or chemoradiotherapy) as N0 and four were staged as N+ (one patient was staged as N1, two were N2c and one was N3). In the 28 N0 patients, 52 elective dissections were performed, and in the 4 N+ patients, 7 therapeutic neck dissections were performed, based on pre-operative investigations.

A total of 1277 lymph nodes were retrieved from the 59 neck dissections. Of the 1277 nodes, 17 (1.3 per cent) were positive in 6 patients. Only two patients clinically staged as N0 (following primary RT or chemoradiotherapy) were proven to have occult metastasis on post-operative pathological examination. This gives an occult metastasis rate (per neck) of only 2 out of 52 (4 per cent).

No patients were down-staged from clinical N+ (following primary RT or chemoradiotherapy) to pathological N0 (post-surgery).

The sensitivity, specificity, and positive and negative predictive values are outlined in Table I.

Table I Diagnostic value of CT in detecting post-chemoradiotherapy neck metastasis

CT = computed tomography

Complications

The very high rate of complications suffered by this patient cohort has been described previously.Reference Scotton, Cobb, Pang, Nixon, Joshi and Jeannon6 In brief, more than half of our patients had post-operative infections despite antibiotic prophylaxis. All patients with wound infections ultimately developed pharyngocutaneous fistulas at an average of 12 days post-operatively.

Univariate analysis revealed three variables with significant correlation to wound infection: alcohol consumption (p = 0.01), clinical lymph node metastasis stage (p < 0.01) and pre-operative albumin levels of less than 3.2 g/l (p = 0.012). Transoesophageal puncture was not associated with a higher risk of complications. The time delay from completion of RT or chemoradiotherapy and salvage surgery was correlated with post-operative complications. The median time interval in patients that developed fistulas was 16.5 months whereas those who did not develop fistulas underwent surgery an average 27 months later.

Tumour stage was not associated with an increased risk of complications. Counterintuitively, N0 was associated with more complications than N+ disease, despite the fact that the former group underwent selective neck dissection at levels 2–4, compared with modified radical neck dissection in the N+ group.

Discussion

Laryngeal cancer is the only cancer for which survival rates have worsened over the last 20 years.Reference Hoffman, Porter, Karnell, Cooper, Weber and Langer7, Reference Olsen8 The reasons for this have been contested,Reference Olsen8Reference Forastiere10 but potentially include worsening co-morbidities and the increasing use of RT or chemoradiotherapy as the primary treatment modality.

Although surgeons’ workload for primary laryngectomy has decreased, the need for salvage laryngectomy has increased. Indeed, persistent or recurrent disease following RT or chemoradiotherapy has been reported to be as high as 50 per cent.Reference Ganly, Patel, Matsuo, Singh, Kraus and Boyle11

In some of these patients, salvage surgery is still feasible and can achieve cure. However, the effects of high-dose RT and chemotherapy on tissue mean that these patients are at a higher risk for post-operative complications.Reference Bohannon, Desmond, Clemons, Magnuson, Carroll and Rosenthal2, Reference Weber, Berkey, Forastiere, Cooper, Maor and Goepfert3, Reference Tabet and Johnson12 Salvage surgery is defined as ‘clean-contaminated’ surgery, and local wound infection rates range from 40 to 61 per cent.Reference Penel, Lefebvre, Fournier, Sarini, Kara and Lefebvre13Reference Wakisaka, Murono, Kondo, Furukawa and Yoshizaki16 The reasons for this high complication rate are discussed elsewhere, but it seems to be driven more by the extent of surgery than by nodal stage.Reference Penel, Lefebvre, Fournier, Sarini, Kara and Lefebvre13, Reference Ogihara, Takeuchi and Majima17, Reference Penel, Fournier, Lefebvre and Lefebvre18 Chemoradiation also seems to be associated with more complications than RT,Reference Sassler, Esclamado and Wolf15, Reference Morgan, Breau, Suen and Hanna19, Reference Bieri, Bentzen, Huguenin, Allal, Cozzi and Landmann20 though we found no significant difference, which is in agreement with an earlier study.Reference Lavertu, Bonafede, Adelstein, Saxton, Strome and Wanamaker21

Given the above, the surgeon must be convinced of the survival benefit of carrying out a neck dissection before recommending it to a patient. This survival benefit is clear in N+ patients, but the question of how much occult disease is missed on pre-operative investigation is a matter of contention. If pre-operative investigation was reliable, we could spare the patient the morbidity of an elective neck dissectionReference Bohannon, Desmond, Clemons, Magnuson, Carroll and Rosenthal2, Reference Farrag, Lin, Cummings, Koch, Flint and Califano4, Reference Wax and Touma5, Reference Yao, Roebuck, Holsinger and Myers22, Reference Gilbert, Branstetter and Kim23 without impacting on oncological outcome. On the other hand, this might be the last chance for cure that the patient has, and if the occult metastasis rate is too high, then the surgeon should recommend elective neck dissection.Reference Yao, Roebuck, Holsinger and Myers22, Reference Mendenhall, Parsons, Brant, Stringer, Cassisi and Million24 It must also be emphasised that despite aggressive treatment, the overall prognosis for these patients is dire, with a five-year overall survival rate of less than 50 per cent.

Novel pre-operative staging techniques

In the primary laryngectomy setting, despite the variety of possible investigations (endoscopy, MRI, CT, positron emission tomography (PET), or ultrasound with or without FNAC), it is not uncommon for the pre-operative investigation to either over-estimateReference Matsuo, Patel, Singh, Wong, Boyle and Kraus25 or under-estimateReference Tankere, Camproux, Barry, Guedon, Depondt and Gehanno26Reference Pitman, Johnson and Myers29 the extent of disease. Overall, occult metastasis rates of roughly 30 per cent are reported for primaries of the oral cavity, oropharynx and larynx.Reference Shah30

In order to increase the accuracy of pre-operative staging and reduce the occult metastasis rate, several new techniques have been tested. Three of the more promising techniques are PET-CT, sentinel lymph node biopsy and diffusion-weighted MRI.

The PET-CT technique has been widely studied, and has been reported to have a significant therapeutic impact in changing the management of patients undergoing surveillance.Reference Perie, Hugentobler, Susini, Balogova, Grahek and Kerrou31 A review of studies on PET-CT for recurrent laryngeal cancer found pooled estimate sensitivity of 89 per cent and specificity of 74 per cent.Reference Brouwer, Hooft, Hoekstra, Riphagen, Castelijns and de Bree32 However, few studies have addressed regional disease specifically. A recent publication on the use of PET-CT for detecting regional disease in patients undergoing salvage laryngectomy concluded that the negative predictive value was too low to allow conservative management of the neck.Reference Gilbert, Branstetter and Kim23

Sentinel lymph node biopsy is gaining popularity in the management of early oral SCC, with negative predictive values of more than 95 per cent.Reference Pezier, Nixon, Gurney, Schilling, Hussain and Lyons33 Though there are reports of sentinel lymph node biopsy used in recurrent carcinoma of the vulva,Reference de Hullu, Piers, Hollema, Aalders and van der Zee34 and in oral or oropharyngeal cancer,Reference Flach, Broglie, van Schie, Bloemena, Leemans and de Bree35 to date there are no published studies on recurrent laryngeal cancer. In theory, the post-RT or post-chemoradiotherapy neck may well have aberrant drainage patterns, and it is unclear whether this would make sentinel lymph node biopsy unreliable. The technique would also need some modification to allow ‘on-table’ injection of the nanocolloid.

Diffusion-weighted MRI has only recently been introduced for head and neck cancers.Reference Thoeny36 In the setting of post-RT or post-chemoradiotherapy laryngeal cancer, it has been reported to have better sensitivity and specificity than PET-CT (up to 96 per cent and 100 per cent in some seriesReference Tshering Vogel, Zbaeren, Geretschlaeger, Vermathen, De Keyzer and Thoeny37), although this is not specifically in terms of evaluating the neck. There is little doubt though that diffusion-weighted MRI complements existing techniques and can be easily added to routine follow-up protocols.

Limitations

There remains a concern that micro-metastatic deposits of tumour in the neck will be well under the resolution of even the most advanced imaging technique. Furthermore, these micro-metastases might be currently under-estimated as they may be missed on routine pathological examination.Reference van den Brekel, Stel, van der Valk, van der Waal, Meyer and Snow38 Indeed, roughly 10 per cent of historical pathologically staged N0 neck specimens show micro-metastasis on careful re-analysis.

  • Various imaging and minimally invasive interventional techniques are available to stage the neck in primary and salvage laryngectomy

  • Computed tomography has better negative predictive value in ruling out neck metastasis in salvage rather than primary laryngectomy

  • Salvage neck dissection is associated with a high risk of complications

  • Conservative management may be considered for the clinically node-negative neck in the salvage laryngectomy setting

This raises the possibility that our pathologically staged N0 patients actually did have micro-metastatic disease resected during elective neck dissection. This would presumably have a survival benefit though the exact survival significance of micro-metastatic disease is controversial. For example, Bohannon et al. Reference Bohannon, Desmond, Clemons, Magnuson, Carroll and Rosenthal2 and Temam et al. Reference Temam, Koka, Mamelle, Julieron, Carmantrant and Marandas39 showed no survival benefit associated with elective neck dissection in the pathologically staged N0 neck. This implies that the impact of any micro-metastatic disease missed on routine pathological examination would be too small to have a significant effect on survival.

Conclusion

Although limited by small numbers and its retrospective nature, our data suggest that the rate of occult neck disease in the salvage laryngectomy patient group is low. With the high rates of post-operative complications associated with salvage neck dissection, a conservative approach to the neck may be considered for patients clinically staged as N0 (following primary RT or chemoradiotherapy). This would help to limit the significant morbidity of salvage surgery without adversely affecting the oncological outcome. Larger, preferably prospective studies are needed to further evaluate this suggestion.

Footnotes

Presented orally at the European Congress on Head and Neck Oncology Meeting, 18–21 April 2012, Poznan, Poland and at the British Association of Head and Neck Oncologists Meeting, 26–27 April 2012, London, UK, and presented as a poster at the American Head and Neck Societies Meeting, 21–25 July 2012, Toronto, Canada.

References

1Forastiere, AA, Goepfert, H, Maor, M, Pajak, TF, Weber, R, Morrison, W et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8CrossRefGoogle ScholarPubMed
2Bohannon, IA, Desmond, RA, Clemons, L, Magnuson, JS, Carroll, WR, Rosenthal, EL. Management of the N0 neck in recurrent laryngeal squamous cell carcinoma. Laryngoscope 2010;120:5861Google Scholar
3Weber, RS, Berkey, BA, Forastiere, A, Cooper, J, Maor, M, Goepfert, H et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003;129:44–9Google Scholar
4Farrag, TY, Lin, FR, Cummings, CW, Koch, WM, Flint, PW, Califano, JA et al. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer. Laryngoscope 2006;116:1864–6CrossRefGoogle ScholarPubMed
5Wax, MK, Touma, BJ. Management of the N0 neck during salvage laryngectomy. Laryngoscope 1999;109:47CrossRefGoogle ScholarPubMed
6Scotton, W, Cobb, R, Pang, L, Nixon, I, Joshi, A, Jeannon, JP et al. Post-operative wound infection in salvage laryngectomy: does antibiotic prophylaxis have an impact? Eur Arch Otorhinolaryngol 2012;269:2415–22CrossRefGoogle ScholarPubMed
7Hoffman, HT, Porter, K, Karnell, LH, Cooper, JS, Weber, RS, Langer, CJ et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:113CrossRefGoogle ScholarPubMed
8Olsen, KD. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010;32:17CrossRefGoogle ScholarPubMed
9Wolf, GT. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited. Head Neck 2010;32:714CrossRefGoogle Scholar
10Forastiere, AA. Larynx preservation and survival trends: should there be concern? Head Neck 2010;32:1417Google Scholar
11Ganly, I, Patel, SG, Matsuo, J, Singh, B, Kraus, DH, Boyle, J et al. Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 2009;31:1489–95Google Scholar
12Tabet, JC, Johnson, JT. Wound infection in head and neck surgery: prophylaxis, etiology and management. J Otolaryngol 1990;19:197200Google ScholarPubMed
13Penel, N, Lefebvre, D, Fournier, C, Sarini, J, Kara, A, Lefebvre, JL. Risk factors for wound infection in head and neck cancer surgery: a prospective study. Head Neck 2001;23:447–55Google Scholar
14Velanovich, V. A meta-analysis of prophylactic antibiotics in head and neck surgery. Plast Reconstr Surg 1991;87:429–34Google Scholar
15Sassler, AM, Esclamado, RM, Wolf, GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162–5CrossRefGoogle ScholarPubMed
16Wakisaka, N, Murono, S, Kondo, S, Furukawa, M, Yoshizaki, T. Post-operative pharyngocutaneous fistula after laryngectomy. Auris Nasus Larynx 2008;35:203–8CrossRefGoogle ScholarPubMed
17Ogihara, H, Takeuchi, K, Majima, Y. Risk factors of postoperative infection in head and neck surgery. Auris Nasus Larynx 2009;36:457–60Google Scholar
18Penel, N, Fournier, C, Lefebvre, D, Lefebvre, JL. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 2005;41:294303CrossRefGoogle ScholarPubMed
19Morgan, JE, Breau, RL, Suen, JY, Hanna, EY. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2007;133:1014Google Scholar
20Bieri, S, Bentzen, SM, Huguenin, P, Allal, AS, Cozzi, L, Landmann, C et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 2003;179:390–5CrossRefGoogle ScholarPubMed
21Lavertu, P, Bonafede, JP, Adelstein, DJ, Saxton, JP, Strome, M, Wanamaker, JR et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401–6CrossRefGoogle ScholarPubMed
22Yao, M, Roebuck, JC, Holsinger, FC, Myers, JN. Elective neck dissection during salvage laryngectomy. Am J Otolaryngol 2005;26:388–92CrossRefGoogle ScholarPubMed
23Gilbert, MR, Branstetter, BF 4th, Kim, S. Utility of positron-emission tomography/computed tomography imaging in the management of the neck in recurrent laryngeal cancer. Laryngoscope 2012;122:821–5Google Scholar
24Mendenhall, WM, Parsons, JT, Brant, TA, Stringer, SP, Cassisi, NJ, Million, RR. Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx? Radiother Oncol 1989;14:199202CrossRefGoogle ScholarPubMed
25Matsuo, JM, Patel, SG, Singh, B, Wong, RJ, Boyle, JO, Kraus, DH et al. Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 2003;238:412–21CrossRefGoogle ScholarPubMed
26Tankere, F, Camproux, A, Barry, B, Guedon, C, Depondt, J, Gehanno, P. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 2000;110:2061–5Google Scholar
27van den Brekel, MW, van der Waal, I, Meijer, CJ, Freeman, JL, Castelijns, JA, Snow, GB. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996;106:987–91CrossRefGoogle ScholarPubMed
28Alex, JC, Krag, DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 1996;5:3341CrossRefGoogle ScholarPubMed
29Pitman, KT, Johnson, JT, Myers, EN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1997;123:917–22CrossRefGoogle ScholarPubMed
30Shah, JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990;160:405–9Google Scholar
31Perie, S, Hugentobler, A, Susini, B, Balogova, S, Grahek, D, Kerrou, K et al. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2007;137:647–53CrossRefGoogle ScholarPubMed
32Brouwer, J, Hooft, L, Hoekstra, OS, Riphagen, II, Castelijns, JA, de Bree, R et al. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 2008;30:889–97CrossRefGoogle ScholarPubMed
33Pezier, T, Nixon, IJ, Gurney, B, Schilling, C, Hussain, K, Lyons, AJ et al. Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma–a prospective case series. Ann Surg Oncol 2012;19:3528–33Google Scholar
34de Hullu, JA, Piers, DA, Hollema, H, Aalders, JG, van der Zee, AG. Sentinel lymph node detection in locally recurrent carcinoma of the vulva. BJOG 2001;108:766–8Google ScholarPubMed
35Flach, GB, Broglie, MA, van Schie, A, Bloemena, E, Leemans, CR, de Bree, R et al. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck. Oral Oncol 2012;48:85–9Google Scholar
36Thoeny, HC. Diffusion-weighted MRI in head and neck radiology: applications in oncology. Cancer Imaging 2011;10:209–14Google Scholar
37Tshering Vogel, DW, Zbaeren, P, Geretschlaeger, A, Vermathen, P, De Keyzer, F, Thoeny, HC. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 2012;23:562–9CrossRefGoogle ScholarPubMed
38van den Brekel, MW, Stel, HV, van der Valk, P, van der Waal, I, Meyer, CJ, Snow, GB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 1992;249:349–53Google Scholar
39Temam, S, Koka, V, Mamelle, G, Julieron, M, Carmantrant, R, Marandas, P et al. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma. Head Neck 2005;27:653–8CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Kaplan–Meier survival curves following salvage laryngectomy. DRFS = distant recurrence free survival; LRRFS = locoregional recurrence free survival; DSS = disease-specific survival; OS = overall survival

Figure 1

Fig. 2 Kaplan–Meier overall survival curves for patients pathologically staged as node-positive (‘ypN + ’) versus those staged as node-negative (‘ypN0’) (p > 0.05).

Figure 2

Table I Diagnostic value of CT in detecting post-chemoradiotherapy neck metastasis